Egos has a reduced capacity to predicts GBS prognosis in Northeast Brazil
dc.contributor.author | Dourado Junior, Mário Emílio Teixeira | |
dc.contributor.author | Fernandes, Ugor T. | |
dc.contributor.author | Ramos, Eugênio S. | |
dc.contributor.author | Vital, Ana L. F. | |
dc.contributor.author | Urbano, João C. C. | |
dc.contributor.author | Queiroz, José W. | |
dc.contributor.author | Jeronimo, Selma M. B. | |
dc.contributor.authorID | https://orcid.org/0000-0002-9462-2294 | pt_BR |
dc.date.accessioned | 2023-07-27T19:41:54Z | |
dc.date.available | 2023-07-27T19:41:54Z | |
dc.date.issued | 2018 | |
dc.description.resumo | Objective: The Erasmus Guillain Barre Outcome Score (EGOS) is a prognostic model that predicts the chance of being able to walk independently at 6 months after Guillain Barré syndrome (GBS). This study was conducted aiming to determine the validity of EGOS in a Brazilian population.Material and Methods: Data collected from GBS patients in Rio Grande do Norte, Brazil, were used to determine the validity of EGOS. GBS disability score was as-sessed in the second week of disease and at 6 months.Results: A total of 206 subjects were studied. The Brazilian patients were younger, with a more severe clinical presentation, with higher percentage of cranial nerve in-volvement and upper respiratory infection. There was no difference relative to sex or presence of anti- gangliosides antibodies. The demyelinating variant was more com-mon (73.9%). However, only 24% of the Brazilians with EGOS 5.5-7 were not able to walk after 6 months, compared to 52% to European Group. Nine patients (3.8%) pre-sented nodopathies, of these four had an EGOS >5, but only one of the latter group was unable to walk after 6 months of GBS.Conclusions: Erasmus Guillain Barre Outcome Score was not a good predictor for the ability to walk after 6 months of GBS in Rio Grande do Norte, Brazil. Differences could be that the Brazilian GBS were younger, or alternatively, it could be due to a different infection profile or in the incidence of nodopathies. | pt_BR |
dc.identifier.citation | DOURADO JÚNIOR, Mário Emílio Teixeira; FERNANDES, Ugor T.; RAMOS, Eugênio S.; VITAL, Ana L. F.; URBANO, João C. C.; QUEIROZ, José W.; JERONIMO, Selma M. B.. Egos has a reduced capacity to predicts GBS prognosis in Northeast Brazil. Acta Neurologica Scandinavica, [S.L.], v. 138, n. 5, p. 459-462, 12 jul. 2018. Hindawi Limited. http://dx.doi.org/10.1111/ane.12995. Disponível em: https://onlinelibrary.wiley.com/doi/10.1111/ane.12995. Acesso em: 19 jul. 2023. | pt_BR |
dc.identifier.doi | https://onlinelibrary.wiley.com/doi/10.1111/ane.12995 | |
dc.identifier.uri | https://repositorio.ufrn.br/handle/123456789/54238 | |
dc.language | en | pt_BR |
dc.publisher | Wiley | pt_BR |
dc.subject | guillain-barré syndrome | pt_BR |
dc.subject | nerve conduction study | pt_BR |
dc.subject | neuropathies | pt_BR |
dc.subject | peripheral neuropathies | pt_BR |
dc.subject | prognosis | pt_BR |
dc.title | Egos has a reduced capacity to predicts GBS prognosis in Northeast Brazil | pt_BR |
dc.type | article | pt_BR |
Arquivos
Licença do Pacote
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- license.txt
- Tamanho:
- 1.45 KB
- Formato:
- Item-specific license agreed upon to submission
Nenhuma Miniatura disponível